Valor IV Pharma Holdings, LLC 13D and 13G filings for Harmony Biosciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 6:10 pm Sale |
2024-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
Valor IV Pharma Holdings, LLC | 6,654,747 11.700% |
-4,592,686 (-40.83%) |
Filing |
| 2024-02-13 7:06 pm Purchase |
2023-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
Valor IV Pharma Holdings, LLC | 11,247,433 19.200% |
10,845 (+0.10%) |
Filing |
| 2023-02-13 5:04 pm Purchase |
2022-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
Valor IV Pharma Holdings, LLC | 11,236,588 18.900% |
14,350 (+0.13%) |
Filing |
| 2022-02-10 4:46 pm Purchase |
2021-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
Valor IV Pharma Holdings, LLC | 11,222,238 19.200% |
4,205 (+0.04%) |
Filing |
| 2021-02-16 06:54 am Purchase |
2020-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY |
Valor IV Pharma Holdings, LLC | 11,218,033 19.700% |
11,218,033 (New Position) |
Filing |